Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs-Reference-Cited by-同舟云学术

Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs

Published:2015 Issue: Volume: Page:291-331
ISSN:2210-7371
Container-title:Non-Biological Complex Drugs
language:
Short-container-title:

Author:

Rodrigo Isabel,Caruncho Sofía,Alonso Concepción,Gómez-Outes Antonio,Mulloy Barbara

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-16241-6_9

Reference123 articles.

1. Achour O, Bridiau N, Godhbani A et al (2013) Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity. Carbohydr Polym 97:684–689

2. Akl EA, Barba M, Rohilla S et al (2008) Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a Cochrane systematic review. J Exp Clin Cancer Res 27:21

3. Al Dieri R., Wagenvoord R, van Dedem GW et al (2003). The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif–the C-domain. J Thromb Haemost 1:907–914

4. Alam F, Al-Hilal TA, Chung SW et al (2014) Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid. Biomaterials 35:6543–6552

5. Anon (2014a) Heparins, low-molecular-mass. In: European Pharmacopoeia, 8.0 (ed), European Directorate For The Quality of Medicines and Healthcare, Strasbourg, 2392–2394

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copies of nonbiological complex drugs: generic, hybrid or biosimilar?;Drug Discovery Today;2019-01